MSN Lab receives approval from the CDSCO Panel to manufacture and market a combo kit containing Macitentan 10 mg and Tadalafil 20 mg.

Published Date: 11 Sep 2023

New Delhi: The Subject Expert Committee (SEC), which functions under, has approved a waiver for a Phase III clinical trial and a bioequivalence (BE) study.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot